Lupus Research Alliance Applauds U.S. FDA Approval of AstraZeneca’s anifrolumab-fnia (Saphnelo™) for Systemic Lupus Erythematosus (SLE)
First in New Class of Drugs in More than a Decade for SLE Targeting Type 1 Interferons
NEW YORK, NY....
Dr. Mary Crow
Leading with Extraordinary Clarity and Grace
Leading with Extraordinary Clarity and Grace
The LRA is enormously grateful to Mary K. (Peggy) Crow, MD for her more...
Breadth of Clinical Research Presented at the 2019 ACR/ARP Annual Meeting Brings Hope for New Lupus Treatments
November 14, 2019
The Lupus Research Alliance staff was on the ground at the 2019 ACR/ARP Annual Meeting and highly...